ALNY vs LNN · P/E 76, rev $1.29B vs P/E 21, rev $676.4M
Alnylam Pharmaceuticals Inc (ALNY) versus Lindsay Corporation (LNN) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Lindsay Corporation (LNN) is a farm & heavy construction machinery company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported LNN revenue for 2025-08-31 was $676.4M. Net income was $74.1M. LNN currently screens at market cap $1.61B and trailing P/E 21.3.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. LNN currently screens at market cap $1.61B and trailing P/E 21.3.
Not investment advice. Open the ALNY and LNN stock pages for the full models.
Not investment advice.